Borgström L, Kågedal B, Paulsen O
Eur J Clin Pharmacol. 1986;31(2):217-22. doi: 10.1007/BF00606662.
N-Acetylcysteine was given intravenously and as three fast dissolving and one slow-release formulation, on separate occasions, as a single dose of 600 mg to 10 fasting (5 men and 5 women) healthy volunteers. Blood and urine were sampled for the following 12 h. Renal clearance constituted around 30% of total body clearance, which was 0.21 l/h/kg. Volume of distribution was 0.33 l/kg, consistent with distribution mainly to extracellular water. The late elimination half-life was 2.27 h and the mean residence time 1.62 h. The slow-release tablet resulted in a flattened plasma concentration-time curve typical of slow release formulations, while the other three oral formulations were rapidly absorbed. The oral availability of N-acetylcysteine varied between 6 and 10%, with the slow-release tablet having the lowest and the fast dissolving tablet the highest availability.
对10名空腹(5名男性和5名女性)健康志愿者,在不同时间分别静脉注射N-乙酰半胱氨酸,并给予三种速溶制剂和一种缓释制剂,单次剂量为600毫克。在接下来的12小时内采集血液和尿液样本。肾清除率约占全身清除率的30%,全身清除率为0.21升/小时/千克。分布容积为0.33升/千克,这与主要分布于细胞外液一致。消除后期半衰期为2.27小时,平均驻留时间为1.62小时。缓释片呈现出缓释制剂典型的平缓血浆浓度-时间曲线,而其他三种口服制剂吸收迅速。N-乙酰半胱氨酸的口服生物利用度在6%至10%之间,其中缓释片的生物利用度最低,速溶片的生物利用度最高。